July 28, 2012 | Global economic turmoil has affected the drug industry, but regulatory leaders from North America and Europe opened the 2012 DIA convention saying that safety and science must not be compromised for the sake of jobs that might be created if rules were relaxed.  

"We all live in a world where there are important politics that pound at the door," said Margaret Hamburg, commissioner of the U.S. Food and Drug Administration. "Science must be the critical tool that guides us in our decision making." Hamburg joined Paul Glover of Health Canada and Guido Rasi of the European Medicines Agency in a panel discussion about international regulatory collaboration at the Drug Information Association's 48th annual meeting in Philadelphia. Philadelphia Inquirer